Natural killer cells target antibody-bound cells following engagement of the Fc receptor CD16. Srpan et al. (2018. J. Cell Biol. https:// doi .org/ 10 .1083/ jcb .201712085) reveal that activation-induced shedding of CD16 leads to more motile behavior, allowing more targets to be engaged and killed in a given time.
In this issue, Srpan et al. addressed the question of how NK cell stimulation through the different types of activatory receptors influence release of cytotoxic agents such as perforin and killing of subsequent target cells. By capturing and quantifying released perforin on a single-cell level, they observed that repeated stimulation of human primary NK cells through activation of either CD16 or NKG2D led to a progressive reduction in perforin release. Intracellular perforin stores were also reduced after each degranulation event, which one might assume indicates simple cell exhaustion following multiple degranulations. Interestingly, however, robust perforin release was recovered in cells stimulated through CD16 if they were subsequently activated through NKG2D. Conversely, activating cells in the inverse order (i.e., NKG2D then CD16) did not restore high levels of perforin secretion. This was caused by reduced surface CD16 in response to activation through either receptor, whereas NKG2D expression was down-regulated only by its own activation, not CD16 ligation. This indicates for the first time that the order of NK cell contacts influences subsequent responses. It also suggests a hierarchy of receptors, where NKG2D can regulate CD16 but not vice versa. Signaling from both CD16 and NKG2D increases the surface activity of the metalloprotease ADAM17, which specifically cleaves CD16 to shed its antibody-binding ectodomain (Romee et al., 2013) . In contrast, down-regulation of NKG2D occurs through ubiquitin-mediated endocytic recycling (Molfetta et al., 2016) that does not appear to be activated by CD16 signaling.
Nonetheless, as little as 1% of the granule contents of an NK cell is sufficient to kill a target (Gwalani and Orange, 2018) , so the critical threshold for regulation may be quite high. Through coincubation of human primary NK cells with antibody-coated or MICA-expressing cells, Srpan et al. (2018) observed that target killing was strongly affected by the order of contact. Killing of antibody-coated cells reduced by a third when NK cells had previously encountered MICA-expressing cells, whereas exposure to antibody-coated cells did not affect subsequent killing of those expressing MICA. To track the encounters of individual NK cells, Srpan et al. (2018) observed cells in microwells using timelapse microscopy. NK cells first engaging a MICA-expressing cell became extremely refractory to killing of a subsequent antibody-coated cell. Indeed, activation of NKG2D resulted in even more potent CD16 inhibition than activation of CD16 itself, since initial killing of an antibody-coated cell did not reduce killing of either a second such cell or one expressing MICA.
Why, then, would NK cells make themselves less conducive to antibody-driven killing during successive engagements, particularly when serial killing by individual cells is important for robust population-level killing (Choi and Mitchison, 2013; Vanherberghen et al., 2013) ? Typically the loss of CD16 has been interpreted as detrimental to NK cell responses. Multiple studies have suggested that large CD16 low NK cell populations persist in chronic infections such as HIV (e.g., Liu et al., 2009) , and therapeutic inhibition of CD16 cleavage serves to increase NK cell activity in such scenarios and during cancer immunotherapy (Zhou et al., 2013) . However, Srpan et al. (2018) observed that inhibition of ADAM17 substantially decreased the rate of NK cell detachment from target cells, without affecting the killing efficiency of an individual contact. A similar effect was observed in NK cells expressing an uncleavable CD16 mutant, reducing the proportion of cells releasing killed targets from 70% to 10%. Consequently, each NK cell was capable of killing fewer target cells in a given timeframe, instead becoming stalled in long-lived contacts (several hours) with a small number of cells. Srpan et al. (2018) observed that, within a 3D matrix, NK cells frequently formed contacts with three or more cells in an 8-h period, but this was reduced substantially by inhibition of ADAM17, whereas death of NK cells in contact with targets increased from 23% to 38%.
CD16 cleavage did not simply increase detachment after killing, but also influenced the underlying structure of the cell-cell contact. In examining the organization of filamentous actin, which accumulates at the periphery of stable immunological synapses (Fig. 1 A) , Srpan et al. (2018) noted that NK cells on antibody-coated surfaces typically formed asymmetric contacts, termed "kinapses," and migrated rapidly, whereas those on MICA-coated surfaces formed synapses and were relatively static. Inhibition of CD16 shedding promoted more stable, static synapses. Kinapses are motile contacts that can lead to durable (several hours) or transient interactions depending on whether the recognition system driving adhesion and polarization is continuous or spatially distinct (Mayya et al., 2018) . Thus, the spatial distribution of target cells in tissues in vivo may also impact whether NKG2D or CD16 engagement leads to serial encounters or more durable interactions. NK cells targeting tumor cells though NKG2D in vivo form kinapses rather than synapses (Deguine et al., 2010) , in contrast to the in vitro observations of Srpan et al. (2018) . Interestingly, simultaneous engagement of CD16 and NKG2D in the same system induced more synapse-like interactions (Deguine et al., 2012) , though changes in CD16 or NKG2D expression in the tumor-infiltrating NK cells was not investigated. Srpan et al. (2018) therefore provide a new conceptual framework in which to view the design and interpretation of experiments to understand and exploit the interplay between killing efficiency and kinapse-dependent tumor penetration in immunotherapy. Their observations also raise a number of further questions. Why is CD16 seemingly the only NK cell receptor to be regulated in this manner? Shedding of NKG2D ligands MICA and MICB (which are also cleaved by ADAM17; Chitadze et al., 2013) may have a comparable effect in vivo, or perhaps CD16 uniquely requires receptor-specific shedding because the strength of the antibody-antigen interaction is variable and cannot be controlled for. Do CD16-mediated contacts inherently result in kinapses or is the first encounter more synaptic in nature? Are CD16 low populations in infection or cancer indications of impaired or highly active NK cell responses? Further study of the nature of NK cell kinapse dynamics, particularly in vivo, will be required to answer these and other outstanding questions. 
